Esperion Therapeutics
ESPR
#6732
Rank
NZ$0.83 B
Marketcap
$4.23
Share price
2.49%
Change (1 day)
115.10%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of June 2024 : -NZ$0.59 Billion

According to Esperion Therapeutics's latest financial reports the company has -NZ$0.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-NZ$0.72 Billion41.08%
2022-12-31$-NZ$0.51 Billion76.87%
2021-12-31$-NZ$0.29 Billion116.41%
2020-12-31$-NZ$0.14 Billion-549.78%
2019-12-31$NZ$29.62 M-74.89%
2018-12-31$NZ$0.11 B-65.77%
2017-12-31$NZ$0.34 B4.4%
2016-12-31$NZ$0.33 B-21.37%
2015-12-31$NZ$0.41 B146.23%
2014-12-31$NZ$0.17 B89.06%
2013-12-31$NZ$90.16 M-526.52%
2012-12-31$-NZ$21.14 Million172.39%
2011-12-31$-NZ$7.77 Million
2002-12-31$NZ$74.02 M-53.77%
2001-12-31$NZ$0.16 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$0.74 B-225.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$9.26 B-1,672.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$158.43 B-26,989.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.19 B-8,619.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.30 B-151.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.41 B-169.72%๐Ÿ‡บ๐Ÿ‡ธ USA